RESEARCH GRANT 2021
We are pleased to announce the 2021 round of the Neuroendocrine Cancer UK Research Grant in support of NET research. This is open to basic science, clinical and translational researchers from investigators across all healthcare disciplines in the UK and Ireland. Applications are invited from UKINETS members. Funds supporting the grant have been raised by Neuroendocrine Cancer UK and UKINETS. The aim of this grant is to provide pump-priming funds to support research projects designed to improve outcomes for patients with Neuroendocrine Tumours and is not to be utilised as part of a bigger research programme.
Ambitious proposals that encourage collaborations between centres are encouraged. It is anticipated that these grants will lead to more substantive grant funding and applicants are required to provide a clear development plan as part of the proposal. Proposals are welcome from researchers in all relevant fields of neuroendocrine tumour research, including all GEP tumours, bronchial and rectal NETs, adrenal and medullary thyroid cancers. However, small cell cancer of lung is beyond the remit of this funding stream. The funds are to be used to cover research costs but not travel expenses, salaries or major equipment.
Instructions for completion
Recent Grant Awardees
Huge congratulations to Dr Marc Ooft, Consultant Histopathologist, King’s College Hospital – the recipient of the 2020 NCUK Research Grant. The grant will fund a study entitled ‘Improving patient stratification through epigenetic and tumour microenvironment analysis of the 100,000 Genomes project Neuroendocrine tumour cohort.’
The 2020 grant was awarded at our 18th National Conference Online, and is supported by NCUK, including a generous donation of £10,000 from Mr P Moxham
Since 2013 there have been 6 research grants awarded through funds raised by Neuroendocrine Cancer UK (formerly NET Patient Foundation) and UKINETs. The objective of these grants is to offer support for NET research groups to obtain pilot data leading to larger comprehensive studies. To date, all recipients have achieved this objective.
For each grant call there has been an enthusiastic response from NET research groups throughout the UK. The quality of the applications to date has been extremely high, and following external peer review, four applications have been funded. The projects funded to date are summarized below and have furthered our knowledge of NET epidemiology, early diagnosis and biology.
The TransNETS committee was replaced by the UKINETs Research Committee in early 2016. This committee will oversee the application process and award of future NET Patient Foundation grants.
Dr Chrissie Thirlwell, Chair, UKINETS Research Committee